1.Renal Fibrosis and Mitochondrial Damage.
Jiao QIN ; Zhang-Zhe PENG ; Qian LI ; Rui WEN ; Li-Jian TAO
Chinese Medical Journal 2018;131(22):2769-2772
2.Critical hubs of renal ischemia-reperfusion injury: endoplasmic reticulum-mitochondria tethering complexes.
Huan-Huan ZHAO ; Qiu-Xia HAN ; Xiao-Nan DING ; Jing-Yao YAN ; Qi LI ; Dong ZHANG ; Han-Yu ZHU
Chinese Medical Journal 2020;133(21):2599-2609
Mitochondrial injury and endoplasmic reticulum (ER) stress are considered to be the key mechanisms of renal ischemia-reperfusion (I/R) injury. Mitochondria are membrane-bound organelles that form close physical contact with a specific domain of the ER, known as mitochondrial-associated membranes. The close physical contact between them is mainly restrained by ER-mitochondria tethering complexes, which can play an important role in mitochondrial damage, ER stress, lipid homeostasis, and cell death. Several ER-mitochondria tethering complex components are involved in the process of renal I/R injury. A better understanding of the physical and functional interaction between ER and mitochondria is helpful to further clarify the mechanism of renal I/R injury and provide potential therapeutic targets. In this review, we aim to describe the structure of the tethering complex and elucidate its pivotal role in renal I/R injury by summarizing its role in many important mechanisms, such as mitophagy, mitochondrial fission, mitochondrial fusion, apoptosis and necrosis, ER stress, mitochondrial substance transport, and lipid metabolism.
Endoplasmic Reticulum/metabolism*
;
Endoplasmic Reticulum Stress
;
Humans
;
Mitochondria
;
Mitochondrial Membranes/metabolism*
;
Mitophagy
;
Reperfusion Injury/metabolism*
3.The role of mitochondria-associated endoplasmic reticulum membranes in age-related cardiovascular diseases.
Yu ZHANG ; Xin-Yi ZHAO ; Wen-Jun XIE ; Yi ZHANG
Acta Physiologica Sinica 2023;75(6):799-816
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are the physical connection sites between mitochondria and endoplasmic reticulum (ER). As the compartments controlling substance and information communications between ER and mitochondria, MAMs were involved in the regulation of various pathophysiological processes, such as calcium homeostasis, mitochondrial morphology and function, lipid metabolism and autophagy. In the past decades, accumulating lines of evidence have revealed the pivotal role of MAMs in diverse cardiovascular diseases (CVD). Aging is one of the major independent risk factors for CVD, which causes progressive degeneration of the cardiovascular system, leading to increased morbidity and mortality of CVD. This review aims to summarize the research progress of MAMs in age-related CVD, and explore new targets for its prevention and treatment.
Humans
;
Mitochondrial Membranes
;
Cardiovascular Diseases/metabolism*
;
Calcium Signaling/physiology*
;
Mitochondria/physiology*
;
Endoplasmic Reticulum/metabolism*
4.Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity.
Ji Hoon JEON ; Dong Keon KIM ; Youngmi SHIN ; Hee Yeon KIM ; Bomin SONG ; Eun Young LEE ; Jong Kwang KIM ; Hye Jin YOU ; Heesun CHEONG ; Dong Hoon SHIN ; Seong Tae KIM ; Jae Ho CHEONG ; Soo Youl KIM ; Hyonchol JANG
Experimental & Molecular Medicine 2016;48(12):e277-
A small proportion of cancer cells have stem-cell-like properties, are resistant to standard therapy and are associated with a poor prognosis. The metabolism of such drug-resistant cells differs from that of nearby non-resistant cells. In this study, the metabolism of drug-resistant lung adenocarcinoma cells was investigated. The expression of genes associated with oxidative phosphorylation in the mitochondrial membrane was negatively correlated with the prognosis of lung adenocarcinoma. Because the mitochondrial membrane potential (MMP) reflects the functional status of mitochondria and metastasis is the principal cause of death due to cancer, the relationship between MMP and metastasis was evaluated. Cells with a higher MMP exhibited greater migration and invasion than those with a lower MMP. Cells that survived treatment with cisplatin, a standard chemotherapeutic drug for lung adenocarcinoma, exhibited increased MMP and enhanced migration and invasion compared with parental cells. Consistent with these findings, inhibition of mitochondrial activity significantly impeded the migration and invasion of cisplatin-resistant cells. RNA-sequencing analysis indicated that the expression of mitochondrial complex genes was upregulated in cisplatin-resistant cells. These results suggested that drug-resistant cells have a greater MMP and that inhibition of mitochondrial activity could be used to prevent metastasis of drug-resistant lung adenocarcinoma cells.
Adenocarcinoma*
;
Cause of Death
;
Cisplatin
;
Humans
;
Lung*
;
Membrane Potential, Mitochondrial
;
Metabolism
;
Mitochondria
;
Mitochondrial Membranes
;
Neoplasm Metastasis
;
Oxidative Phosphorylation
;
Parents
;
Prognosis
5.The cytosolic domain of Bcl-2 oligomerizes to form pores in model mitochondrial outer membrane at acidic pH.
Jun PENG ; Suzanne M LAPOLLA ; Zhi ZHANG ; Jialing LIN
Journal of Biomedical Engineering 2009;26(3):631-637
The three dimensional structures of both pro-apoptotic Bax and anti-apoptotic Bcl-2 are strikingly similar to that of pore-forming domains of diphtheria toxin and E. coli colicins. Consistent with the structural similarity, both Bax and Bcl-2 have been shown to possess pore-forming property in the membrane. However, these pore-forming proteins form pores via different mechanisms. While Bax and diphtheria toxin form pores via oligomerization, the colicin pore is formed only by colicin monomers. Although the oligomers of Bcl-2 proteins have been found in the mitochondria of both healthy and apoptotic cells, it is unknown whether or not oligomerization is involved in the pore formation. To determine the mechanism of Bcl-2 pore formation, we reconstituted the pore-forming process of Bcl-2 using purified proteins and liposomes. We found that Bcl-2 pore size depended on Bcl-2 concentration, and the release of smaller entrapped molecules was faster than that of larger ones from liposomes at a given Bcl-2 concentration. Moreover, the rate of dye release mediated by pre-formed wild-type Bcl-2 oligomers or by the mutant Bcl-2 monomers with a higher homo-association affinity was much higher than that by wild-type Bcl-2 monomers. Together, it is suggested that oligomerization is likely involved in Bcl-2 pore formation.
Apoptosis
;
physiology
;
Cytosol
;
metabolism
;
Humans
;
Hydrogen-Ion Concentration
;
Liposomes
;
metabolism
;
Mitochondrial Membrane Transport Proteins
;
metabolism
;
Mitochondrial Membranes
;
metabolism
;
Protein Multimerization
;
Proto-Oncogene Proteins c-bcl-2
;
metabolism
6.Mammalian mitochondrial RNAs are degraded in the mitochondrial intermembrane space by RNASET2.
Peipei LIU ; Jinliang HUANG ; Qian ZHENG ; Leiming XIE ; Xinping LU ; Jie JIN ; Geng WANG
Protein & Cell 2017;8(10):735-749
Mammalian mitochondrial genome encodes a small set of tRNAs, rRNAs, and mRNAs. The RNA synthesis process has been well characterized. How the RNAs are degraded, however, is poorly understood. It was long assumed that the degradation happens in the matrix where transcription and translation machineries reside. Here we show that contrary to the assumption, mammalian mitochondrial RNA degradation occurs in the mitochondrial intermembrane space (IMS) and the IMS-localized RNASET2 is the enzyme that degrades the RNAs. This provides a new paradigm for understanding mitochondrial RNA metabolism and transport.
Cell Line
;
Humans
;
Mitochondrial Membranes
;
metabolism
;
Protein Transport
;
RNA
;
biosynthesis
;
chemistry
;
metabolism
;
RNA Stability
;
RNA, Mitochondrial
;
Ribonucleases
;
metabolism
;
Tumor Suppressor Proteins
;
metabolism
7.Blueberry attenuates liver injury in metabolic dysfunction-associated liver disease by promoting the expression of mitofilin/Mic60 in human hepatocytes and inhibiting the production of superoxide.
Ya REN ; Houmin FAN ; Lili ZHU ; Tao LIN ; Tingting REN
Chinese Journal of Cellular and Molecular Immunology 2023;39(4):318-324
Objective To study the effect and mechanism of blueberry on regulating the mitochondrial inner membrane protein mitofilin/Mic60 in an in vitro model of metabolic dysfunction-associated liver disease (MAFLD). Methods L02 human hepatocytes were induced by free fatty acids (FFA) to establish MAFLD cell model. A normal group, a model group, an 80 μg/mL blueberry treatment group, a Mic60 short hairpin RNA (Mic60 shRNA) transfection group, and Mic60 knockdown combined with an 80 μg/mL blueberry treatment group were established. The intracellular lipid deposition was observed by oil red O staining, and the effect of different concentrations of blueberry pulp on the survival rate of L02 cells treated with FFA was measured by MTT assay. The levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), superoxide dismutase (SOD) activity, glutathione (GSH) and malondialdehyde (MDA) contents were measured by visible spectrophotometry. The expression of reactive oxygen species (ROS) in hepatocytes was observed by fluorescence microscopy, and the mRNA and protein expression of Mic60 were detected by real-time quantitative PCR and Western blot analysis, respectively. Results After 24 hours of FFA stimulation, a large number of red lipid droplets in the cytoplasm of L02 cells was observed, and the survival rate of L02 cells treated with 80 μg/mL blueberry was higher. The results of ALT, AST, TG, TC, MDA and the fluorescence intensity of ROS in blueberry treated group were lower than those in model group, while the levels of SOD, GSH, Mic60 mRNA and protein in blueberry treated group were higher than those in model group. Conclusion Blueberry promotes the expression of Mic60, increases the levels of SOD and GSH in hepatocytes, and reduces the production of ROS, thus alleviating the injury of MAFLD hepatocytes and regulating the disorder of lipid metabolism.
Humans
;
Blueberry Plants/chemistry*
;
Hepatocytes/metabolism*
;
Liver/metabolism*
;
Liver Diseases/metabolism*
;
Reactive Oxygen Species/metabolism*
;
Superoxide Dismutase/metabolism*
;
Superoxides/metabolism*
;
Mitochondrial Membranes/metabolism*
;
Mitochondrial Proteins/metabolism*
;
Plant Extracts/pharmacology*
8.Ultrastructural Changes in Skeletal Muscle of Infants with Mitochondrial Respiratory Chain Complex I Defects.
Ji Young MUN ; Min Kyo JUNG ; Se Hoon KIM ; Soyong EOM ; Sung Sik HAN ; Young Mock LEE
Journal of Clinical Neurology 2017;13(4):359-365
BACKGROUND AND PURPOSE: The pathogenesis of mitochondrial disease (MD) involves the disruption of cellular energy metabolism, which results from defects in the mitochondrial respiratory chain complex (MRC). We investigated whether infants with MRC I defects showed ultrastructural changes in skeletal muscle. METHODS: Twelve infants were enrolled in this study. They were initially evaluated for unexplained neurodegenerative symptoms, myopathies, or other progressive multiorgan involvement, and underwent muscle biopsies when MD was suspected. Muscle tissue samples were subjected to biochemical enzyme assays and observation by transmission electron microscopy. We compared and analyzed the ultrastructure of skeletal muscle tissues obtained from patients with and without MRC I defects. RESULTS: Biochemical enzyme assays confirmed the presence of MRC I defects in 7 of the 12 patients. Larger mitochondria, lipid droplets, and fused structures between the outer mitochondrial membrane and lipid droplets were observed in the skeletal muscles of patients with MRC I defects. CONCLUSIONS: Mitochondrial functional defects in MRC I disrupt certain activities related to adenosine triphosphate synthesis that produce changes in the skeletal muscle. The ultrastructural changes observed in the infants in this study might serve as unique markers for the detection of MD.
Adenosine Triphosphate
;
Biopsy
;
Electron Transport*
;
Energy Metabolism
;
Enzyme Assays
;
Humans
;
Infant*
;
Lipid Droplets
;
Microscopy, Electron, Transmission
;
Mitochondria
;
Mitochondrial Diseases
;
Mitochondrial Membranes
;
Muscle, Skeletal*
;
Muscular Diseases
9.The cytosolic domain of Bcl-2 forms small pores in model mitochondrial outer membrane after acidic pH-induced membrane association.
Jun PENG ; Suzanne M LAPOLLA ; Zhi ZHANG ; Jialing LIN
Journal of Biomedical Engineering 2009;26(1):130-137
The permeability of mitochondrial outer membrane (MOM) is regulated by the proteins of the Bcl-2 family via their interactions at the membrane. While pro-apoptotic Bax protein promotes MOM permeabilization (MOMP) releasing cytochrome c after activation by BH3-only protein, anti-apoptotic Bcl-2 protein protects MOM. However both Bax and Bcl-2 can form pores in model membranes. Unlike Bax pore that has been extensively studied and reported to be directly linked to MOMP, Bcl-2 pore is much less known; thus we investigated the pore-forming property of recombinant Bcl-2 lacking the C-terminal transmembrane sequence (Bcl-2deltaTM) in liposomal membranes of MOM lipids. We found that: (1) Bcl-2 formed pores at acidic pH that induced the association of Bcl-2 with liposome; (2) Bcl-2 pore size was dependent on Bcl-2 concentration, suggesting that oligomerization is involved in Bcl-2 pore formation; (3) Unlike Bax pore that could release large molecules up to 2 mega-Da, Bcl-2 pore was smaller and could only release the molecules of a few kilo-Da. Therefore, Bcl-2 and Bax may form different size pores in MOM, and while the large pore formed by Bax may release cytochrome c during apoptosis, the small pore formed by Bcl-2 may maintain the normal MOM permeability.
BH3 Interacting Domain Death Agonist Protein
;
metabolism
;
Cell Membrane Permeability
;
Cytochrome c Group
;
metabolism
;
Humans
;
Hydrogen-Ion Concentration
;
Liposomes
;
metabolism
;
Mitochondrial Membrane Transport Proteins
;
metabolism
;
Mitochondrial Membranes
;
metabolism
;
bcl-2-Associated X Protein
;
metabolism
;
bcl-X Protein
;
metabolism
10.Experimental study on the glutamine's intervention effect on the opening of permeability transition pore in myocardial mitochondrial membrane.
Chinese Journal of Applied Physiology 2012;28(1):34-37
OBJECTIVETo explore the intervention effect and the possibly mechanism of the glutamine (Gln) on the opening change of the permeability transition pore (PTP) in the myocardial mitochondrial membrane under the overtraining state.
METHODS30 SD rats were randomly divided into 3 groups (n = 10): control group (CG group), overtraining group (OG group) and supplementary (Gln) + overtraining group group). Spectrophotometry was used to test the openness of the permeability transition pore in the myocardial mitochondrial membrane. Electrochemistry was used to test the malondialdehyde (MDA) and the glutathione (GSH) content and the phospholipase A2 (PLA2) activity.
RESULTSOG group compared with the GOG group, the absorbance (A0) and the absorbance change (Delta A) were decreased significantly (P < 0.05). Rh123 fluorescence (F0) intensity was significantly increased (P < 0.05). Rhodamine123 (Rh123) fluorescence change (delta F) was significantly decreased (P < 0.05). Compared with the GOG, the mitochondrial GSH was significantly decreased (P < 0.05), the PLA2 activity and the content of MDA were significantly increased (P <0.05).
CONCLUSIONOvertraining could lead to opening increase of permeability transition pore in the myocardial mitochondrial membrane, after overtraining, the production of the reactive oxygen species (ROS) and PLA2 activity were increased, GSH content was decreased. But added exogenous Gln had a significant intervention effect for these changes.
Animals ; Glutamine ; pharmacology ; Glutathione ; metabolism ; Male ; Mitochondria, Heart ; drug effects ; physiology ; Mitochondrial Membrane Transport Proteins ; metabolism ; Mitochondrial Membranes ; drug effects ; physiology ; Myocardium ; metabolism ; Permeability ; Rats ; Rats, Sprague-Dawley ; Reactive Oxygen Species ; metabolism